Moreover, compared with Hdac9+/+Apoe−/− mice, Hdac9−/−Apoe−/− mice exhibited reduced atherosclerotic lesion size throughout the aorta [49], making HDAC9 a plausible target for pharmacologic prevention of atherosclerosis. This evidence concerns the gene HDAC9 and atherosclerosis.